EBERS has won a €2.4 million tender titled Pre-Commercial Procurement for the Development of Innovative Solutions in the Field of Organ Preservation, opened by the Spanish Center for the Development of Industrial Technology (CDTI). The works will be executed in collaboration with Moses Products, a company specialized in plastic transformation, and Intraven, an SME specialized in the assembly, packaging and sterilization of medical devices.
We summarize below the most relevant aspects of the contract:
EBERS’ CEO, Pedro Moreo, participated in the symposium on “Cutting-edge Regenerative Medicine” organized by Clínica Universidad de Navarra and CIMA research institute. He gave his view on the current situation of organ transplantation and presented the latest results obtained in the NORMOPERF (normoperf.eu) project financed by the European Commission.
This week it was celebrated the annual meeting of the BRAVE project (projectbrave.eu, @brav3_eu), led by Dr. Felipe Prósper from Clínica Universidad de Navarra. It was great to see and meet in person the rest of partners of the consortium and discover how much progress has been done so far. On EBERS’ side, it was exciting to show to the partners the new cell culture bioreactor that has been designed in collaboration with Leartiker and Boston Scientific, which is ready for the first cell culture validation tests.